GSK Stops Additional Three Respiratory Virus Vaccine Trials In Pregnant Women
GlaxoSmithKline Plc (NYSE: GSK) has halte
Does CBD Have To Be Water Soluble? One Group Of Scientists Say Yes For Better Absorption
Several former scientists and staff from companies like Johnson & Johnson (NYSE: JNJ), GlaxoSmithKline (NYSE: GSK) and Schiff Nutrition are bringing a new delivery platform to market that boosts the bioavailability of&
AstraZeneca, GSK’s COVID-19 Therapies Lose Efficacy Against Omicron’s Subvariants
The FDA authorized an increased dose in the case of AstraZeneca Plc's (NASDAQ:
Sanofi-GSK Prepare Regulatory Filings For COVID-19 Vaccine After Booster Data
Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline plc (NYSE: GSK) are
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries.
Moderna Adds Three New mRNA-Based Development Programs To Its Pipeline
Moderna Inc (NASDAQ: MRNA) said it is deve
GlaxoSmithKline Paused Late-stage Trial of Respiratory Syncytial Virus Vaccine in Pregnant Women
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that it has voluntarily paused enrolment and vaccination in the GRACE phase III trial (NCT04605159), evaluating its potential respiratory syncytial virus (RSV) maternal vaccine candidate, as well as two other trials investigating this candidate in pregnant women (NCT04980391, NCT05229068).
GlaxoSmithKline: Q4 Earnings Insights
GlaxoSmithKline (NYSE:GSK) reported its Q4 earnings results on Wednesday, February 9, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.